Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Yoshifumi Iwagami, MD, PhD"'
Autor:
Yuichiro Okumura, MD, Takehiro Noda, MD, PhD, Hidetoshi Eguchi, MD, PhD, Yoshifumi Iwagami, MD, PhD, Daisaku Yamada, MD, PhD, Tadafumi Asaoka, MD, PhD, Hiroshi Wada, MD, PhD, Koichi Kawamoto, MD, PhD, Kunihito Gotoh, MD, PhD, Yutaka Takeda, MD, PhD, Masahiro Tanemura, MD, PhD, Shigeru Marubashi, MD, PhD, Koji Umeshita, MD, PhD, Yuichiro Doki, MD, PhD, Masaki Mori, MD, PhD
Publikováno v:
Transplantation Direct, Vol 3, Iss 9, p e207 (2017)
Background. Tacrolimus is the key immunosuppressive drug for liver transplantation. Once-daily prolonged-release tacrolimus (TAC-PR) exhibits good drug adherence but has difficulty controlling the trough level in the early phase of liver transplantat
Externí odkaz:
https://doaj.org/article/8634380351fe4de9bbe388d9058eefb2